Stopped: Enrollment rates to the trial were lower than projected and anticipated.
This trial examines the usefulness of two educational programs for parents with late-stage cancer who have a 5 - 17 year old child. The programs are designed to enhance the quality of the parent-child relationship and add to the parent's confidence in managing the impact of their cancer on their child. Educational programs may reduce anxiety and depression and improve the well-being and quality of life of parents with advanced cancers and their children. Recruitment occurs nationally via referral to the Fred Hutch/University of Washington Cancer Consortium team.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Treatment efficacy assessed by parents' mood (CES-D)
Timeframe: At 3 months post-baseline
Treatment efficacy assessed by parents' anxiety [Spielberger State-Trait Anxiety (STAI, state scale)]
Timeframe: At 3 months post-baseline
Parent's confidence in being able to talk with her child about the child's cancer-related concerns (CASE Help Child Subscale)
Timeframe: At 3 months post-baseline
Parents' skills in helping their child cope and manage the toll of the parents' cancer (Connecting and Coping Subscale)
Timeframe: At 3 months post-baseline
Child-Behavioral Emotional Functioning: Anxious/Depressed, Internalizing, Externalizing scores on CBCL
Timeframe: At 3 months post-baseline